aid: adcentrxtherapeutics name: Adcentrx Therapeutics description: 'Adcentrx Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, California, developing next-generation antibody-drug conjugates (ADCs) and protein conjugate therapeutics for cancer and other life-threatening diseases. Its proprietary i-Conjugation technology platform pairs stable conjugation chemistry and protease-cleavable linkers with novel small-molecule payloads; the clinical pipeline includes ADRX-0706 (Nectin-4) and ADRX-0405 (STEAP1). The company was surfaced via the API Evangelist harvest backlog (source: secondary-market). It publishes a corporate and investor-relations website only — no developer program, API, SDK, or machine-readable specification of any kind was found.' image: https://www.adcentrx.com/wp-content/uploads/2021/11/Adcentrx-logo.png url: https://raw.githubusercontent.com/api-evangelist/adcentrxtherapeutics/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: stub x-tier-reason: harvest specificationVersion: '0.20' created: '2026-09-07' modified: '2026-09-07' tags: - Company - Biotechnology - Pharmaceuticals - Life Sciences - Oncology - Healthcare - Clinical Stage - Antibody Drug Conjugates apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/adcentrxtherapeutics-domain-security.yml - type: Website url: https://www.adcentrx.com/ - type: About url: https://www.adcentrx.com/about/ - type: Blog url: https://www.adcentrx.com/news/ - type: BlogRSS url: https://www.adcentrx.com/feed/ - type: Support url: https://www.adcentrx.com/contact/ - type: TermsOfService url: https://www.adcentrx.com/terms-of-use/ - type: PrivacyPolicy url: https://www.adcentrx.com/privacy-policy/ - type: LinkedIn url: https://www.linkedin.com/company/adcentrx-therapeutics x-enrichment: date: '2026-09-07' status: minimal artifacts_added: 2 pass: local-v3 x-coverage: state: none reason: not-a-software-company detail: >- Adcentrx Therapeutics is a clinical-stage oncology biotech developing antibody-drug conjugates (ADRX-0706, ADRX-0405); its only web property is a SiteGround-hosted WordPress corporate/investor site whose entire path space answers HTTP 202 with an sg-captcha robot challenge, and no api., docs., developer. or portal. host exists in DNS - the site nav, read from an Internet Archive snapshot, has no developer section. evidence: - url: https://www.adcentrx.com/ status: 202 - url: https://www.adcentrx.com/.well-known/api-catalog status: 202 - url: https://www.adcentrx.com/openapi.json status: 202 - url: http://web.archive.org/web/20260810050011/https://www.adcentrx.com/ status: 200 checked: '2026-09-07'